Predictive
Genetic
Testing
&
Consumer/Wellness Genomics Market - Global
Industry Analysis, Size, Share, Growth, Trends,
and Forecast 2017 - 2025
The type of genetic testing which is employed to diagnose or predict the gene
mutation or genetic changes linked to a disease is called predictive genetic testing.
It is usually used in a symptomatic person to check future risks. The branch of
genomics concerned with the sequencing and interpretation of the individual is
called consumer genomics, while the one which predicts the genetic factors
contributing to healthy living is called wellness genomics. This type of testing
enables a person to make good lifestyle changes and choices.
The rising health care awareness and shifting population preference toward a
healthy lifestyle have led to the expansion of the market for predictive genetics
testing & consumer/wellness genomics. Factors such as the rising attention of the
government and other private regulatory bodies toward public health care,
increased effectiveness & quality of genetic testing, prevalence of chronic diseases
& genetic diseases such as Parkinson’s & cystic fibrosis are expected to drive the
global predictive genetics testing & consumer genomics market during the forecast
period. Furthermore, the rising need to understand one’s family history is propelling
the global market as well. However, stringent regulatory rules and ethics for the
approval of genetic testing could limit the market’s development through 2025.
View Report @
http://www.transparencymarketresearch.com/predictive-genetic-testing-
consumerwellness-genomics-market.html
In terms of test type, the global predictive genetics testing & consumer/wellness
genomics market can be categorized into the predictive testing, consumer
genomics, and wellness genomics segments. Predictive testing can be further
divided into the genetic susceptibility testing, predictive diagnostic, and population
screening sub-segments. On the basis of application, the global market can be split
into the following groups: cancer screening, cardiovascular screening,
musculoskeletal screening, diabetic screening, Parkinson’s / Alzheimer disease
screening, and others.
Geographically, the global predictive genetics testing & consumer/wellness
genomics market is distributed over North America, Latin America, Europe, Asia
Pacific, and Middle East & Africa. North America held a major market share, followed